figures-supplemental g&d revised...
TRANSCRIPT
-6
-1
4
Log 2
(Fol
d C
hang
e)
-11
-6
-1
Log 2
(Fol
d C
hang
e)
Bub1b
Cdc20
Cdc27
Cdc40
Dcp1a
Lin7c mos
pcm1
pum2
suz1
2
-5
-1
3
MI MIIGV
Log 2
(Fo
ld C
hang
e)
Polysome microarray
Polysome qPCR
RNP qPCR
Total qPCR
0
5
1 0
1 5
Fold
Cha
nge
Bmp6
Dppa3
Hnrnph
3
Syvn1
Ywhae
-5
-1
Log 2
(Fol
d C
hang
e)
0
1
2
Fold
Cha
nge
Polysome qPCR
Polysome microarray
A
B
Chen_Fig.S2
-9
-5
-1
Log 2
(Fol
d C
hang
e)
0
1
2
Fold
Cha
nge
-11
-6
-1
4
Log 2
(Fol
d C
hang
e)
CPEB1
Eif4a3 Fzr1
Rpl26
Rpl36
Rpl5
Rps17
actin
Cd151
GAPDH
Mapk3
Med7
Miox
paip2
Pfdn5
QarsRim
kla
Stx5a
Tinf2
-5
-1
Log 2
(Fo
ld C
hang
e)Polysome microarray
Polysome qPCR
RNP qPCR
Total qPCR
Decreased unstable Decreased stable Chen_Fig.S3
D
A
BGV MI MII
0
1000
2000
3000
4000
*
**
Fluo
resc
ence
Inte
nsity
(arb
itrar
y un
its)
0 2 4 60.0
2.5
5.0
7.5
10.0
*
**
14
**
Time after hCG (h)
CC
NB
1 pr
otei
n le
vels
(Fol
d C
hang
e)
E
Chen_Fig.S4
C
GV MI MII0.0
2.5
5.0
7.5PolysomeSubpolysome/RNP
0
25
50
75
100
125
Fold
Cha
nge
(pol
ysom
e qP
CR
) % of G
V stage(total and R
NPs qPC
R)
Total qPCR
Chen_Fig.S5
0
1000
2000
3000
4000
5000
6000
7000
8000 Snapc5Tomm6PisdNdufb5Gnl3Glrx3RNAset2bDnajb6Polr3hTrappc2lCdc2aSpc24Rps27
GV MI MIIFl
uore
scen
ce In
tens
ity(A
ribi
trar
y U
nits
)
0
1000
2000
3000
4000
5000 Pxmp4SnRpbChcd10Rps20Nrd1Map2k4Wdr91EndogAspscr1Ai413782SnrbpElovl1Glrx3
GV MI MII
Fluo
resc
ence
Inte
nsity
(Ari
bitr
ary
Uni
ts)
Anapc
1(143
4444
_s_a
t)
Anapc
1(143
4443
_at)
Anapc
1(141
5680
_at)
Anapc
2(141
5707
_at)
Anapc
4(142
3930
_at)
Anapc
4(142
3931
_s_a
t)
Anapc
5(143
5177
_a_a
t)
Anapc
5(143
5178
_x_a
t)
Anapc
5(141
6906
_at)
Anapc
5(143
3822
_x_a
t)
Anapc
5(145
3307
_a_a
t)
Anapc
5(145
6695
_x_a
t)
Anapc
7(141
8458
_at)
Anapc
10(14
2937
5_at)
Anapc
10(14
2937
6_s_
at)
Anapc
13(14
5258
6_at)
Cdc16
(1425
554_
a_at)
Cdc20
(1416
664_
at)
Cdc27
(1426
076_
at)
Cdc27
(1433
848_
at)
Cdc27
(1433
849_
at)
Cdc27
(1454
739_
at)
Cdc26
(1423
987_
at)
Fzr1(14
1945
1_at)
0
1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0
5 0 0 0
G VM IM II
Fluo
resc
ence
Inte
nsity
(Arb
itrar
y Un
its)
Spindle Assembly Checkpoint (SAC)
Mad2l1
(1422
460_
at)
Mad2l2
(1460
348_
at)
Bub3(1
4168
15_s
_at)
Bub3(1
4484
73_a
t)
Bub1b
(1416
961_
at)
Bub1b
(1447
362_
at)
Bub1b
(1447
363_
s_at)
0
1000
2000
3000
4000
5000
6000
7000
8000GVMIMII
Fluo
resc
ence
inte
nsity
(arb
itrar
y un
its)
Apc1
Apc2Apc11
Apc5
Apc4Cdc23Cdc16
Cdc27
Apc13Cdc26
Apc10
Apc9
APC core
=
APC/cyclosome components
Cohesin subunits
stag2
(1421
849_
at)sta
g2(14
5039
6_at)
stag1
(1431
921_
a_at)
stag1
(1421
940_
at)
stag1
(1431
921_
a_at)
stag1
(1434
189_
at)
0
250
500
750
1000
1250
GVMIMII
Fluo
resc
ence
Inte
nsity
(arb
itrar
y un
its)
Chen_Fig.S6
-40
-30
-20
-10 0 10 20 30 40 50 60 70 80 90 100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
260
270
280
2900
10
20
30
40
50
60
70
80
801 unique regulated transcripts with one or more CPEs
Relative position of the putative CPE closest to the Hexamer
Num
ber
of tr
ansc
ript
s
Chen_Fig.S7
0 1 2 3 4 5 6 7 8 9 10 14-10.0
-7.5
-5.0
-2.5
0.0
2.5
5.0
7.5
Number of putative CPEs/transcript
Fold
cha
nge
(log2
)
1371 538 323 155 97 51 27 15 13 4 4 3
Chen_Fig.S8
-8.25
-7.75
-7.25
-6.75
-6.25
-5.75
-5.25
-4.75
-4.25
-3.75
-3.25
-2.75
-2.25
-1.75
-1.25
-0.75
-0.250.2
50.7
51.2
51.7
52.2
52.7
53.2
53.7
54.2
54.7
55.2
55.7
5
0.00
0.05
0.10
0.15
0.20None2 or more CPE
1/fr
eque
ncy
dist
ribu
tion
-8.25
-7.75
-7.25
-6.75
-6.25
-5.75
-5.25
-4.75
-4.25
-3.75
-3.25
-2.75
-2.25
-1.75
-1.25
-0.75
-0.250.2
50.7
51.2
51.7
52.2
52.7
53.2
53.7
54.2
54.7
55.2
55.7
5
0.00
0.05
0.10
0.15
0.20None2 or more Dazl
1/fr
eque
ncy
dist
ribu
tion
Class IClass IIClass III
-8.25
-7.75
-7.25
-6.75
-6.25
-5.75
-5.25
-4.75
-4.25
-3.75
-3.25
-2.75
-2.25
-1.75
-1.25
-0.75
-0.25 0.2
50.7
51.2
51.7
52.2
52.7
53.2
53.7
54.2
54.7
55.2
55.7
5
0.00
0.05
0.10
0.15
0.20 NoneBoth CPE and Dazl
Log2 Fold Changes
1/ r
elat
ive
dist
ribu
tion
Chen_Fig.S9A
B
C
Chen_Fig.S10
Cpeb1
Cpeb3
Cpeb4 Daz
l
Pum2
Msi2
Dazap
1
Dazap
2
Dzip3
0
1000
2000
3000
4000
5000MIIMIGV
*
***
*
****
**Fl
uore
scen
ce In
tens
ity(A
rbitr
ary
Uni
ts)
MO-Con
MO-Daz
l
MO-Daz
l + hD
AZL RNA
0
2 5
5 0
7 5
*
NS
Perc
ent P
olar
Bod
y
MO-Con
MO-Daz
l
MO-Daz
l + hD
AZL*
0
2 5
5 0
7 5
* *
Perc
ent P
olar
Bod
y
A
Chen_Fig.S12
B C
Eif4a3
Gapdh ZP3
DAZLTex
19.1
Bub1b
cdc2
0Tpx
2Arid
1asm
arca5
-2
-1
0
1
2
No Dazlelement
1 or more putativeDazl element
Log 2
Fol
d C
hang
e(r
elat
ive
to C
ontr
ol)
Chen_Fig.S14
2 cell 4-8 cell morula0
25
50
75
100MO-controlMO-DazlMO-Dazl + hDAZL
ND
Dev
elop
ing
Embr
yos
(%)
MO-DazlMO-control MO-Dazl + hDAZL
Chen_Fig.S15
DAZL
ATGTAA
5’3’
ATGTAA5’
3’
ATG TAA AAAA’
DAZL
DAZL
DAZL
Metaphase II
CPEB1
ATGTAA
3’
ATGTAA
3’
ATG TAA 3’
DAZL
ATG TAA 3’
DAZL
DAZL
ATGTAA
’3’
CPEB1
CPEB1
ATGTAA
3’
Phase-specific control of mRNA translation during mouse oocyte maturation
CPEB1Dazl mRNA
AAAAAAA
AAAAAAA
AAAAAAA
AA
Prometaphase I
CPEB4
?
ATGTAA
AAA
Dazl mRNA
Anaphase I
Positivefeedback
Chen_Fig.S16